EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial

Francisco Martínez-Mardones iD, Shalom I Benrimoj iD, Antonio Ahumada-Canale iD, Jose C Plaza-Plaza iD, Victoria Garcia-Cardenas iD

British Journal of Clinical Pharmacology · 2023

DOI: 10.1111/bcp.15682 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2023. Verfasst von Francisco Martínez-Mardones und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health, University of Technology Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases, Dyslipidemias. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Technology Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiovascular diseases (CVD) are the primary cause of death in Chile. Pharmacist‐led medication review with follow‐up (MRF) has improved CVD risk factors control in Europe and North America. However, their healthcare systems differ from Chile's, precluding generalizability. This trial aimed to determine the effect of MRF on CVD risk factor control among older patients with polypharmacy attending public primary care centres in Chile.

Methods

A cluster‐randomized controlled trial was conducted in 24 centres. Patients older than 65 years with moderate‐to‐high CVD risk, five or more medications, hypertension, type 2 diabetes or dyslipidaemia, received MRF in addition to usual care or usual care alone for 12 months. Primary outcome measures were clinical goal achievement for hypertension, type 2 diabetes and dyslipidaemia, as well as medication adherence, medication number and CVD risk score. Adjusted generalized estimating equations were used, with odds ratios (ORs) for binary measures and mean differences for continuous measures.

Results

In total, 324 patients from 12 centres (174 MRF group, 150 usual care group, six centres each) received four pharmacist visits. Significant improvements were found for goal achievement in hypertension (OR 4.37, 95% confidence interval [CI] 2.54 to 7.51, P = .001), LDL cholesterol (OR 3.67, 95% CI 2.13 to 6.33, P = .001), type 2 diabetes (OR 6.97, 95% CI 3.69 to 13.2, P = .001), medication adherence (OR 6.60, 95% CI 1.36 to 31.9, P = .022), medications number (−0.86, 95% CI −1.14 to −0.58, P < .001) and CVD risk score (−2.27, 95% CI −2.84 to −1.69, P < .001).

Conclusion

Pharmacist‐led medication review with follow‐up improved cardiovascular disease risk factor control and medication adherence. This study supports pharmacists' inclusion in primary care teams.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HypertensionCardiovascular DiseasesDyslipidemiasHumansFollow-Up StudiesMedication ReviewPrimary Health CareMedication AdherencePharmacists

Stichwörter der Autor:innen

cardiovascular riskhypertensionmedication reviewspharmacist careprimary caretype 2 diabetes

Autor:innen und Institutionen

  • Graduate School of Health, University of Technology Sydney, Sydney, Australia.
  • Faculty of Pharmacy, University of Granada, Granada, Spain.
  • Macquarie University Centre for the Health Economy, Macquarie Business School & Australian Institute of Health Innovation, Macquarie University, Sydney, Australia.
  • Faculty of Chemistry and Pharmacy, Pontifical Catholic University of Chile, Santiago, Chile.

ORCID-Profile: Francisco Martínez-Mardones, Shalom I Benrimoj, Antonio Ahumada-Canale, Jose C Plaza-Plaza, Victoria Garcia-Cardenas

Förderung

  • University of Technology Sydney

Zitieren

APA

Martínez-Mardones, F., Benrimoj, S. I., Ahumada-Canale, A., Plaza-Plaza, J. C., & Garcia-Cardenas, V. (2023). BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15682

Vancouver

Martínez-Mardones F, Benrimoj SI, Ahumada-Canale A, Plaza-Plaza JC, Garcia-Cardenas V. BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial. British Journal of Clinical Pharmacology. 2023. doi:10.1111/bcp.15682

BibTeX
@article{MartnezMardones2023,
  author = {Martínez-Mardones, Francisco and Benrimoj, Shalom I and Ahumada-Canale, Antonio and Plaza-Plaza, Jose C and Garcia-Cardenas, Victoria},
  title = {BC Clinical impact of medication reviews with follow‐up in cardiovascular older patients in primary care: A cluster‐randomized controlled trial},
  journal = {British Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1111/bcp.15682}
}
Kostenlos starten →